Skip to content

Effect of Sublingual Rye grass immunotherapy (SLI) in clinical finding and skin test of alleric children

Effect of subgluteal Rye grass immunotherapy on cliniccal findings and skin prick test in 6-16 years old patients withallergic rhinitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138810142976N1
Enrollment
24
Registered
2010-05-02
Start date
2010-01-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Allergic rhinitis due to pollen, Allergy NOS due to pollen, Hay fever, Pollinosis

Interventions

Intervention 1: Sublingugal Rye grass administration (Trad Mark Stalergen Company) from 10 IR to 300IR. Intervention 2: plasebo is normal salin with alomin salt that prepraed in similar vials by stall
Treatment - Drugs
Placebo
Sublingugal Rye grass administration (Trad Mark Stalergen Company) from 10 IR to 300IR
plasebo is normal salin with alomin salt that prepraed in similar vials by stallergen company

Sponsors

Zanjan University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 20 Years

Inclusion criteria

Inclusion criteria: Patients with allergic rhinitis, 6-16 years old and sensitive to rye grass by skin prick test are included in study. Children with sever asthma and other chronic diseases and patients who are receiving beta blocker or ACE inhibitor drugs are excluded from study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Improvement of clinical symptoms and skin prick test results. Timepoint: 6 month. Method of measurement: Symptoms and signs scoring and skin prick test.;Negative skin test. Timepoint: 6 month. Method of measurement: Skin prik test.

Secondary

MeasureTime frame
Drug requirment. Timepoint: Durig 6 month contineously asssessed. Method of measurement: Ouestioner.;Specific IgE reduction. Timepoint: After 6 month. Method of measurement: Eliza.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Taymourzadeh

Zanjan University of Medical Science

akefeh45@zums.ac.irzu_afshar@yahoo.com+98 24 1413 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026